ArticleAnalytical chemistry2026
MetaboAnnotate: An AI-powered Multiagent Framework for Integrating Annotation Tools for Untargeted Metabolomics.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A chiral silicon-based electrochemical sensor for the detection of L-glutamate.Mikrochimica acta · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Metabolite annotation remains a major bottleneck in untargeted metabolomics, limiting biological interpretation of large-scale mass spectrometry data sets. Although substantial advances have been made through spectral libraries, machine learning-based annotation models, and community benchmarking efforts, many recently developed tools remain difficult to incorporate into routine workflows because they are distributed as research-oriented software with complex dependencies and nonstandard interfaces. Here, we present MetaboAnnotate, a web-based framework that uses a large language model (LLM) in a multiagent system to orchestrate multiple metabolite annotation tools through a unified natural-language interface. The system enables users to submit MS/MS spectra and execute multitool annotation workflows without local installation or programming expertise. The current implementation integrates complementary methods, including SIRIUS, FLARE, JESTR, and DiffMS. Evaluation on the CASMI 2016 and CASMI 2022 benchmarks shows that agreement among independent annotation tools substantially reduces false discovery rates and improves annotation accuracy. Application to a fecal metabolomics data set further demonstrates the utility of multitool consensus for identifying high-confidence putative metabolites. MetaboAnnotate is available at: https://hassounlab.cs.tufts.edu/MetaboAnnotate/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.